Ethionamide Medium Enhances Stem Cell Migration via CXCR4

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for enhancing stem cell migration ability are inadequate, leading to reduced therapeutic effectiveness in stem cell transplantation, as the mechanisms for promoting mesenchymal stem cell migration post-transplantation are not well understood and existing solutions are insufficient.

Innovation Solution

Incorporating ethionamide into a medium composition, specifically at concentrations of 1 to 500 μM, in Minimum Essential Medium (α-MEM) supplemented with fetus bovine serum and gentamicin, which increases the expression of the CXCR4 gene in stem cells, thereby improving their migration ability without gene manipulation or viral vectors.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional methods are used to enhance stem cell migration, then therapeutic effectiveness is improved, but the mechanisms are not well understood and existing solutions are insufficient

Engineering Contradiction:

Improvetherapeutic effectivenessVSAvoidmechanism understanding

Core Design Contradiction:

ReliabilityVSLoss of information

Solution Approach 1:

The patent changes the chemical parameter of the culture medium by introducing ethionamide at specific concentrations (1-500 μM). This parameter change directly improves stem cell migration capability and upregulates CXCR4 expression, thereby enhancing therapeutic effectiveness while providing a measurable mechanism through gene expression changes.

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent identifies CXCR4 as an intermediary molecule that mediates the effect of ethionamide on stem cell migration. By upregulating CXCR4 expression, ethionamide acts through this intermediary to enhance migration, thus providing both therapeutic improvement and mechanistic understanding through the identified molecular pathway.

Inventive Principle:

Principle #24Intermediary (Mediator)

2Speed

If ethionamide is used to improve stem cell migration, then migration ability is significantly enhanced, but the complexity of the medium composition increases

Engineering Contradiction:

Improvestem cell migration speedVSAvoidmedium composition complexity

Core Design Contradiction:

SpeedVSDevice complexity

Solution Approach 1:

The patent employs ethionamide, which is a conventional antibiotic with known properties, and repurposes it for enhancing stem cell migration. This multi-functional approach allows a single substance to serve both as a culture medium additive and as a migration enhancer, avoiding the need for complex specialized devices or procedures.

Inventive Principle:

Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent optimizes the concentration parameter of ethionamide in the culture medium (1-500 μM range) to achieve effective migration enhancement. By carefully controlling this single parameter, the patent achieves significant migration improvement without requiring complex multi-component formulations or sophisticated delivery systems.

Inventive Principle:

Principle #35Parameter changes

3Speed

If gene manipulation or viral vectors are used to enhance migration, then migration ability is improved, but the safety and simplicity of the method is reduced

Engineering Contradiction:

Improvemigration abilityVSAvoidsafety risks

Core Design Contradiction:

SpeedVSObject-affected harmful factors

Solution Approach 1:

The patent uses a simple chemical additive (ethionamide) in the culture medium instead of permanent genetic modifications. This temporary, reversible approach enhances migration ability during the therapeutic window without introducing long-term safety risks associated with gene manipulation or viral vectors, effectively replacing complex biological tools with a simpler chemical solution.

Inventive Principle:

Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent converts ethionamide, which is traditionally used as an antibiotic, into a beneficial agent for enhancing stem cell migration. By repurposing this conventional drug for a new therapeutic application, the patent avoids the safety risks of experimental gene therapies while leveraging the known safety profile of ethionamide from its established clinical use.

Inventive Principle:

Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Ethionamide significantly enhances the migration of mesenchymal stem cells, as demonstrated by increased cell migration and invasion in assays, and elevated CXCR4 gene expression, facilitating rapid migration to damaged regions and improving therapeutic outcomes.

Implementation Method 1

the medium increases the expression of a chemokine (C-X-C motif) receptor 4 (CXCR4) gene in a stem cell

Methodology Applied

Scientific EffectGene expression regulation:

Data Source

PatentUS11913020B2Method for improving stem cell migration using ethionamide

Publication Date: 2024.02.27 SAMSUNG LIFE PUBLIC WELFARE FOUND

AI summary

The present invention relates to a medium composition for improving stem cell migration, which includes ethionamide, and a use thereof. According to the present invention, the migration of stem cells may be effectively improved by the adjustment of a culture environment, which is a simple and safe method, without using gene manipulation or a viral vector, and the stem cells improved in migration by the method may be effectively used as a stem cell therapeutic agent that is able to function by rapidly migrating to the damaged region after transplantation.